rs148087344

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2

The NM_145117.5(NAV2):​c.333C>T​(p.Leu111Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0059 in 1,614,174 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0050 ( 8 hom., cov: 33)
Exomes 𝑓: 0.0060 ( 39 hom. )

Consequence

NAV2
NM_145117.5 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.0170

Publications

5 publications found
Variant links:
Genes affected
NAV2 (HGNC:15997): (neuron navigator 2) This gene encodes a member of the neuron navigator gene family, which may play a role in cellular growth and migration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BP6
Variant 11-19832549-C-T is Benign according to our data. Variant chr11-19832549-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2641677.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.017 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 8 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NAV2NM_145117.5 linkc.333C>T p.Leu111Leu synonymous_variant Exon 2 of 38 ENST00000349880.9 NP_660093.2 Q8IVL1-3A7E2D6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NAV2ENST00000349880.9 linkc.333C>T p.Leu111Leu synonymous_variant Exon 2 of 38 1 NM_145117.5 ENSP00000309577.6 Q8IVL1-3

Frequencies

GnomAD3 genomes
AF:
0.00497
AC:
757
AN:
152186
Hom.:
8
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000989
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.0164
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00692
Gnomad OTH
AF:
0.00622
GnomAD2 exomes
AF:
0.00524
AC:
1317
AN:
251480
AF XY:
0.00514
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00124
Gnomad ASJ exome
AF:
0.00149
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0156
Gnomad NFE exome
AF:
0.00730
Gnomad OTH exome
AF:
0.00456
GnomAD4 exome
AF:
0.00600
AC:
8766
AN:
1461870
Hom.:
39
Cov.:
32
AF XY:
0.00585
AC XY:
4254
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33480
American (AMR)
AF:
0.00136
AC:
61
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00107
AC:
28
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00157
AC:
135
AN:
86256
European-Finnish (FIN)
AF:
0.0147
AC:
786
AN:
53418
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.00673
AC:
7482
AN:
1111992
Other (OTH)
AF:
0.00411
AC:
248
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
436
873
1309
1746
2182
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
276
552
828
1104
1380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00497
AC:
757
AN:
152304
Hom.:
8
Cov.:
33
AF XY:
0.00525
AC XY:
391
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.000986
AC:
41
AN:
41572
American (AMR)
AF:
0.00275
AC:
42
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
8
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4826
European-Finnish (FIN)
AF:
0.0164
AC:
174
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00692
AC:
471
AN:
68022
Other (OTH)
AF:
0.00616
AC:
13
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
34
67
101
134
168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00585
Hom.:
1
Bravo
AF:
0.00394
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00556
EpiControl
AF:
0.00670

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
May 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NAV2: BP4, BP7 -

NAV2-related disorder Benign:1
Feb 04, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.27
CADD
Benign
11
DANN
Benign
0.77
PhyloP100
0.017
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148087344; hg19: chr11-19854095; COSMIC: COSV100587518; API